Top Section/Ad
Top Section/Ad
Most recent
Submarine mast maker's IPO raised €132.8m
Vincorion is expected to continue defence IPOs later this week
◆ How AI threat to software biz threatens stockmarket listings... ◆ ... and collaterlised loan obligation market ◆ AT1 market hits new record tight but buyers turn away
More articles/Ad
More articles/Ad
More articles
-
Nongfu Spring, a Chinese bottled water and beverage company, has kicked off pre-deal investor education for its Hong Kong IPO. -
Chinese biotechnology company JW (Cayman) Therapeutics is planning to float on Hong Kong’s stock exchange. It has filed a draft prospectus with the bourse.
-
Germany’s CureVac has gone public on the Nasdaq, joining the army of biotech companies that have tapped the equity capital markets for cash during the pandemic, despite growing concern of a brewing dot-com style bubble.
-
Ke Holdings sealed a $2.12bn IPO on the New York Stock Exchange this week, the largest US listing by a Chinese firm in more than two years, defying the shock caused by US sanctions against one of its largest shareholders, Tencent Holdings. Jonathan Breen reports.
-
European equity capital markets are gearing up for a wave of autumn IPOs and are worrying that they will struggle for investor attention. But one of the few good things to have emerged from the coronavirus pandemic — the use of technology to accelerate deal calendars — should alleviate fears of congestion.
-
Europe’s equity capital markets have gone quiet in August as investors take a holiday before what is expected to be a busy September. Bankers are keen to get their deals done quickly when the market reopens to avoid running into bad news on Covid-19 and a volatile US election, meaning investors will be asked to take part in an onslaught of IPOs in a true test of market capacity.
